Literature DB >> 9065981

The perimenopause and affective disorders.

P J Schmidt1, C A Roca, M Bloch, D R Rubinow.   

Abstract

A variety of epidemiologic studies have identified that the majority of postmenopausal women do not experience a depression during the perimenopause. In contrast, results of several epidemiologic studies and clinic-based surveys suggest that a substantial number of perimenopausal women, in fact, do experience a clinically significant depression. In this article, we review these studies. Case examples are described to introduce a discussion of the characteristics of perimenopause-related depression, and we identify several factors occurring during midlife in women that may potentially contribute to mood dysregulation at this time. Finally, we provide suggestions for the evaluation and management of women presenting with perimenopause-related depression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065981     DOI: 10.1055/s-2008-1067971

Source DB:  PubMed          Journal:  Semin Reprod Endocrinol        ISSN: 0734-8630


  9 in total

1.  Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

Authors:  Wendy K Marsh; Joyce T Bromberger; Sybil L Crawford; Katherine Leung; Howard M Kravitz; John F Randolph; Hadine Joffe; Claudio N Soares
Journal:  Menopause       Date:  2017-12       Impact factor: 2.953

Review 2.  Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics.

Authors:  Marie K Osterlund; Michael-Robin Witt; Jan-Ake Gustafsson
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 3.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 4.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.

Authors:  Andrea J Rapkin; Judith A Mikacich; Babak Moatakef-Imani; Natalie Rasgon
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 6.  The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen.

Authors:  B Lee Peterlin; Michael J Katsnelson; Anne H Calhoun
Journal:  Curr Pain Headache Rep       Date:  2009-10

Review 7.  Psychotic and mood disorders associated with the perimenopausal period: epidemiology, aetiology and management.

Authors:  G E Robinson
Journal:  CNS Drugs       Date:  2001       Impact factor: 6.497

8.  Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and Effectiveness.

Authors:  Pasquale De Franciscis; Flavio Grauso; Anna Luisi; Maria Teresa Schettino; Marco Torella; Nicola Colacurci
Journal:  Nutrients       Date:  2017-02-13       Impact factor: 5.717

9.  Perimenopausal and Postmenopausal Health.

Authors:  Angela M Cheung; Ruhee Chaudhry; Moira Kapral; Cynthia Jackevicius; Gail Robinson
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.